Pingfang Cui

Chinese Center For Disease Control and Prevention — China

Medicine · Health Sciences

12h-index970citations24works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(14), Viral gastroenteritis research and epidemiology(8), Viral Infections and Immunology Research(7), COVID-19 Clinical Research Studies(5), Animal Virus Infections Studies(5)

Publications24 total

[Knowledge, attitude, practice and influencing factors on influenza and influenza vaccine among pregnant women in Suzhou].
PubMed·2024· 1 cited
Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein
Vaccines·2023· 4 citedOpen Access
Evaluation of Immunogenicity and Clinical Protection of SARS-CoV-2 S1 and N Antigens in Syrian Golden Hamster
Vaccines·2022· 1 citedOpen Access
Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
Clinical and Translational Medicine·2022· 5 citedOpen Access
Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants
Emerging Microbes & Infections·2021· 6 citedOpen Access
Correction to: Attenuated phenotypes and analysis of a herpes simplex virus 1 strain with partial deletion of the UL7, UL41 and LAT genes
Virologica Sinica·2021Open Access
Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
Vaccine·2021· 5 citedOpen Access
Preclinical Immunological Evaluation of an Intradermally Administered Heterologous Vaccine Against SARS-CoV-2 Variants
2021Open Access
Immunological Identification and Characterization of the Capsid Scaffold Protein Encoded by UL26.5 of Herpes Simplex Virus Type 2
Frontiers in Cellular and Infection Microbiology·2021· 3 citedOpen Access
Heterologous vaccination strategy for containing COVID-19 pandemic
2021· 6 citedOpen Access
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial
Vaccine·2021· 53 citedOpen Access
Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression
PLoS Pathogens·2020· 96 citedOpen Access
Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults
Clinical Infectious Diseases·2020· 72 citedOpen Access
An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine
2020· 14 citedOpen Access
Attenuated phenotypes and analysis of a herpes simplex virus 1 strain with partial deletion of the UL7, UL41 and LAT genes
Virologica Sinica·2017· 13 citedOpen Access
Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations
BMC Medicine·2015· 40 citedOpen Access
Safety and immunogenicity of a live attenuated mumps vaccine
Human Vaccines & Immunotherapeutics·2014· 20 citedOpen Access
An Inactivated Enterovirus 71 Vaccine in Healthy Children
New England Journal of Medicine·2014· 395 citedOpen Access
Celastrus orbiculatus extract induces mitochondrial-mediated apoptosis in human hepatocellular carcinoma cells
Journal of Traditional Chinese Medicine·2012· 33 citedOpen Access
A comparative study of the characteristics of two Coxsackie A virus type 16 strains (genotype B)
Science China Life Sciences·2012· 10 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Yun Liao(21), Ying Zhang(19), Qihan Li(18), Shengtao Fan(13), Lichun Wang(11), Heng Zhao(11), Xingli Xu(11), Dandan Li(10), Guorun Jiang(10), Zhongping Xie(9), Yanchun Che(8), Longding Liu(7), Chenghong Dong(7), Hongling Zhao(7), Zhanlong He(6), Li Yu(6), Xuanyi Wang(5), Li Jiang(5), Ruixiong Na(5), Lei Guo(5)